文献速递临床微生物临床血液与体液分子诊断

联合微生物与病理方法优化幽门螺杆菌感染的诊断与管理:一项7年研究

Optimizing diagnostic utility for diagnosis and management of Helicobacter pylori infections through combined microbiology and pathology approaches: a 7-year study.
PubMed 文献 · Am J Clin Pathol · 2026-01-01

该研究回顾2015年4月至2022年3月华盛顿特区幽门螺杆菌阳性患者(n=31,平均年龄51岁),评估微生物学与外科病理学诊断效用。微生物学初步阳性诊断快3天(P<.00001);胃窦活检标本回收率100%(OR=5.4);抗菌谱显示>55%对一线药物耐药,77%为多重耐药。结论强调活检部位、疾病严重程度及本地抗菌谱对诊疗的重要性。

要点

  • 微生物学检测较病理学提前3天提供初步阳性诊断(P<.00001)。
  • 胃窦活检标本对两种方法均显示100%回收率(OR=5.4)。
  • 本地抗菌谱显示>55%对一线药物耐药,77%分离株多重耐药。

核心结论

  • 幽门螺杆菌准确诊断取决于标本部位与疾病严重程度,合理采集活检并联合微生物与病理检测可最大化诊断效用,本地抗菌谱对经验性治疗至关重要。

研究设计与样本

  • 回顾性观察性研究,纳入2015年4月至2022年3月幽门螺杆菌阳性患者(n=31,平均年龄51岁),查阅电子病历获取人口学、临床表现、实验室结果及临床管理信息。

主要发现

  • 最常见临床表现为腹痛(55%)、胃食管反流病(19%)和恶心/呕吐(10%),84%患者为复发性疾病。
  • 微生物学与外科病理学结果一致(n=105份标本)见于96%患者。
  • 微生物学检测初步阳性诊断快3天(P<.00001)。
  • 胃窦活检标本对两种方法均显示100%回收率(OR=5.4)。
  • 活动性胃炎为最常见诊断(82%),显著增加微生物涂片见幽门螺杆菌(OR=1.7)及活菌回收用于药敏试验(OR=2.6)的可能性。

关键数值与推荐

  • 微生物学初步阳性诊断较病理学快3天(P<.00001)。
  • 胃窦活检标本回收率100%(OR=5.4)。
  • 活动性胃炎增加微生物涂片见菌(OR=1.7)及活菌回收(OR=2.6)可能性。
  • 抗菌谱显示>55%对一线药物耐药,77%分离株多重耐药。

临床怎么用

  • 应合理采集胃窦活检标本并同时送检微生物学与外科病理学以最大化诊断效用。
  • 经验性治疗应参考本地抗菌谱,因该人群>55%对一线药物耐药且77%为多重耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Helicobacter pylori infections result in significant global disease burden related to chronic gastritis, peptic ulcer disease, and gastric cancer. Optimal treatment requires knowledge of local resistance epidemiology. We characterized our patient population infected with H pylori in Washington, DC, United States, and evaluated the diagnostic utility of microbiology and surgical pathology approaches for H pylori diagnosis. METHODS: A retrospective, observational study was performed from April 2015 to March 2022, consisting of patients positive for H pylori. Review of the electronic medical record for patient demographics, clinical presentation, laboratory results, and clinical management was performed. RESULTS: Top clinical presentations in our patients with H pylori infections (n = 31, mean age 51 years) were abdominal pain (55%), gastroesophageal reflux disease (19%), and nausea/vomiting (10%), with most (84%) experiencing recurrent disease. Concordant findings (n = 105 specimens) between microbiology and surgical pathology were noted in 96% of patients. Microbiology testing provided a faster preliminary positive diagnosis by 3 days (P < .00001). For both approaches, antrum biopsy specimens demonstrated a 100% recovery rate (odds ratio [OR], 5.4). Active gastritis was the most common diagnosis (82%), which significantly increased the likelihood of H pylori seen in microbiology smears (OR, 1.7) and viable recovery of the organism (OR, 2.6) for further antimicrobial susceptibility testing. Our antibiogram revealed more than 55% resistance to first-line drugs, with 77% of our isolates being multidrug resistant. CONCLUSIONS: An accurate diagnosis of an H pylori infection is dependent on specimen site and disease severity. Appropriate biopsy collection and ordering of microbiology and surgical pathology tests maximize diagnostic utility. A local antibiogram is essential for guiding empiric therapy.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Tariq Z, Ali M, Yee R, et al. Optimizing diagnostic utility for diagnosis and management of Helicobacter pylori infections through combined microbiology and pathology approaches: a 7-year study. Am J Clin Pathol. 2026. PMID: 42586603. doi:10.1093/ajcp/aqag093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。